MannKind Corp. (Nasdaq: MNKD) stock doubled Wednesday after its inhaled diabetes treatment, Afrezza, was recommended for approval by a Food and Drug Administration (FDA) advisory committee.
In a unanimous 14 to 0 thumbs-up, the group voted Afrezza should be approved for type 2 diabetes, the more common form of the blood sugar disease. In a near-united nod, the group voted 13 to 1 in favor of Afrezza's approval for type 1 diabetes.
Here’s what investors need to know…
U.S. markets today (Tuesday) were headed toward another session of gains. The Dow Jones Industrial Average and Nasdaq were up more than 40 points by 1:30 p.m., and the S&P 500 was up about 6 points.
Investors remain cautious ahead of Friday's closely watched jobs report. Nonetheless, plenty of equities were moving higher on analysts' actions, company news, and earnings.
Here are 12 of Tuesday's hot stocks to watch.
Our best stocks to buy now weekly roundup includes a contrarian tech stock pick from Russia, a marijuana stock that’s avoided hype, and more.
Check out this week's market movers, and why they're on fire...
The roller-coaster ride in Plug Power (Nasdaq: PLUG) stock continues....
Shares of the fuel cell system provider surged 49.03% to $8.48 Tuesday on extremely heavy volume of 137.02 million shares. Sending the stock soaring was a MarketWatch piece noting the company's chief executive officer disclosed he was set to announce a major deal in the next few weeks.
"We signed an additional order in North American with a global automaker," MarketWatch reported PLUG CEO Andy Marsh said in a telephone interview Tuesday.
Here's what is next for Plug Power (Nasdaq: PLUG)...
U.S. stocks jumped right out of the gate Tuesday, hoping to break a two-day losing streak - and this makes for a long list of hot stocks to watch today.
All three major benchmarks were comfortably in the green in morning trading, with the Dow Jones Industrial Average up more than 110 points just minutes after the opening bell.
There were plenty of stocks moving sharply higher on company news, industry developments, analysts' actions, and earnings.
Following are 12 of Tuesday's hot stocks to watch...
We've said it over in Private Briefing many times: There are many reasons insiders sell shares of their company, but there's really only one reason they buy.
They believe their company's share price is headed higher - much higher.
And Eric M. DeMarco, CEO of high-level contractor Kratos Defense & Security Solutions, Inc (Nasdaq: KTOS), just bought 10,000 shares of his own stock.
The transaction took place Monday at $7.17 a share. Kratos zoomed nearly 9.2% yesterday to close at $7.74.
"BP, insiders are the ultimate arbiters of the future market value of a company," Money Map Press Chief Investment Strategist Keith Fitz-Gerald told me yesterday. "They enjoy the benefit of having the full purview of their company's future sales, future contracts, and future profits. They know what's coming down the pike." Full Story
Stocks rallied for a second consecutive day Tuesday, with the S&P 500 Index and Dow Jones Industrial Average up more than half a percentage point and the Nasdaq up 1.25% in intraday trading.
The second 2014 Federal Open Market Committee (FOMC) meeting kicked off this morning, the first to be led by U.S. Federal Reserve Chairwoman Janet Yellen, and markets will be listening closely for any clues regarding possible changes to the Fed's guidance on interest rates.
To continue reading, please click here...
Best stocks to buy for the week ending March 14, 2014: Stock futures suffered worldwide on fallout from the Ukraine. A referendum set for yesterday (Sunday), in which Crimeans voted on whether to become part of Russia or declare independence first, had investors increasingly cautious as the week ticked by.
The Dow Jones Industrial Average ended the week down 2.35% to close at 16,065.67. The Standard & Poor's 500 Index closed down at 1,841.13, a 1.97% loss. And the Nasdaq dropped 1.43% by Friday to close at 4,245.40.
To continue reading, please click here...
It's not often that you get a chance to get in on the "ground floor" of an entire new business.
But that's just what you have here.
In the past, you've heard me say that we are living in the "Golden Age of Materials Science." You see, without Miracle Materials - and the science that backs them - we simply wouldn't have some of the unique high-tech products we take for granted: smartphones, electric cars, and new drug therapies just to name a few.
And this is your chance to get in on the ground floor...
Investors remained guarded Tuesday while reflecting on Wall Street's now 5-year-old rally, soft economic data out of Asia, and mounting tensions in Ukraine.
After a quiet Monday, which saw just 6 million shares change hands (the third lowest-volume day of the year) and left all three benchmarks modestly lower, Tuesday's session was much the same.
To continue reading, please click here...
Best stocks to buy for the week ending March 7, 2014: Geopolitical concerns in Ukraine sparked a shift to gold, crude, and grains early last week, while stock futures suffered. But as the week unfolded, investors came back to the stock markets with cautious optimism...
All eyes were on the Standard & Poor's 500 Index - it closed at 1,878.04 on Friday, marking its fifth record closing high in the past seven sessions. It increased 1% over the course of the week.
To continue reading, please click here...
U.S. equities jumped up right out of the gate Tuesday, with all three benchmarks up better than 1% just before noon. The S&P 500 Index hit yet another record high. European markets, also hammered on Monday, recovered most of what they lost in Tuesday's session.
While the gains were broad-based as stocks rebounded from Monday's rout, there were a number of equities moving higher on company developments, industry news, earnings, and deal making. Following are 12 of today's hot stocks to watch.
Best stocks to buy for the week ending Feb. 28, 2014: The S&P 500 Index finished February up 4.3% at 1,859.45, its best month since October and its best February since 1998.
The Dow Jones Industrial Average ended February 4% higher, trimming year-to-date losses to 1.5%. And the Nasdaq closed out the month up 5%. The tech-heavy index is up 3.2% in 2014 and sits at a 13 1/2-year high.
Five years ago this Sunday, on March 9, 2009, the S&P 500 closed at 676.58, its lowest level since the start of the 2008 financial crisis. Since then, stock returns have more than tripled.
Last year, when I shared my five secrets for uncovering wealth-building tech stocks, I also told you about a sixth "rule" you can use to find the big-time profit opportunities that are flying under Wall Street's radar screen.
I refer to these as "special-situation" investments because they tend to be companies that are grappling with unique challenges. Because of those challenges, analysts tend to ignore these stocks.
And that's good for us.
To continue reading, please click here...
Editor's Note: We're giving you special access to Bill's Private Briefing because spin-offs and deal making are minting new millionaires weekly. Companies are going out to buy growth, and they're bringing trillions of dollars off the sidelines as this niche explodes. Here's Bill...
We love spin-offs.
And it's not just because you were able to cash in on our recommendation of Abbott Laboratories Inc. (NYSE: ABT), whose subsequent breakup into two companies has so far resulted in gains of 27% and 47%.
We love spin-offs because, as a group, they offer high-probability opportunities for market-beating profits. Since the Abbott pick, we've issued reports on several other spin-off opportunities.
Our goal: To help you assemble a portfolio of these "special-situation" profit plays.
Here's the portfolio... Full Story
